Background. Mucolipidosis type 3 gamma (ML–IIIγ) is an autosomal recessive, rare and slowly progressive lysosomal storage disease. Short stature, restricted joint mobility, thick skin, and flat face with mildly coarse features are major clinical findings. It usually manifests in the third year. With advancing age, claw hand deformities, carpal tunnel syndrome, and scoliosis may develop. Morbidity is determined mainly by skeletal involvement. N–acetyl glucosamine–1 phospotransferase enzyme is composed of 2α, 2β and 2γ subunits. The active enzyme is essential in the transport of hydrolases to the lysosomes, via addition of mannose-6-phosphate in the Golgi apparatus. GNPTG gene encodes the γ2 subunits, and biallelic mutations cause ML–IIIγ. Case. A previously healthy 14-year-old male patient had leg pain after the age of nine, and was admitted with short stature, mild coarse face, pectus deformity, digital stiffness, scoliosis, genu valgum and mitral valve prolapse. He did not have intellectual disability or corneal clouding. Radiographs showed irregularities in the acetabular roof and proximal epiphyses of the femur and irregularities in the end plates of vertebral bodies. A novel homozygous missense variant in the exon 5 of GNPTG, c.316G>T, confirmed the diagnosis of ML– IIIγ. Juvenile idiopathic arthritis (JIA), progressive pseudorheumatoid dysplasia (PPRD), ML–II, ML–IIIαβ, galactosialidosis and mucopolysaccharidosis should be considered in the differential diagnosis. Conclusions. ML–IIIγ should be kept in mind in populations with high consanguineous marriage rates or with possible founder effect, in patients with short stature and skeletal destruction. Genetic tests should be planned for a definitive diagnosis.
___
1. Nampoothiri S, Elcioglu NH, Koca SS, et al. Does the clinical phenotype of mucolipidosis-IIIγ differ from its αβ counterpart?: supporting facts in a cohort of 18 patients. Clin Dysmorphol 2019; 28: 7-16. https://doi. org/10.1097/MCD.0000000000000249
2. Khan MA, Hussain A, Sher G, Zubaida B, Naeem M. Genetic testing of a large consanguineous Pakistani family affected with mucolipidosis III gamma through next-generation sequencing. Genet Test Mol Biomarkers 2018; 22: 541-545. https://doi. org/10.1089/gtmb.2018.0123
3. Raas-Rothschild A, Spiegel R. Mucolipidosis III gamma. In: Adam MP, Ardinger HH, Pagon RA, et al. (eds). GeneReviews®. Seattle, WA: University of Washington, 2010.
4. Velho RV, Harms FL, Danyukova T, et al. The lysosomal storage disorders mucolipidosis type II, type III alpha/beta, and type III gamma: update on GNPTAB and GNPTG mutations. Hum Mutat 2019; 40: 842-864. https://doi.org/10.1002/humu.23748
5. Tüysüz B, Kasapçopur Ö, Alkaya DU, Şahin S, Sözeri B, Yeşil G. Mucolipidosis type III gamma: three novel mutation and genotype-phenotype study in eleven patients. Gene 2018; 642: 398-407. https://doi. org/10.1016/j.gene.2017.11.052
6. van Meel E, Kornfeld S. Mucolipidosis III GNPTG missense mutations cause misfolding of the γ subunit of GlcNAc-1-phosphotransferase. Hum Mutat 2016; 37: 623-626. https://doi.org/10.1002/ humu.22993
7. Braulke T, Pohl S, Storch S. Molecular analysis of the GlcNac-1-phosphotransferase. J Inherit Metab Dis 2008; 31: 253-257. https://doi.org/10.1007/s10545- 008-0862-5
8. Oussoren E, van Eerd D, Murphy E, et al. Mucolipidosis type III, a series of adult patients. J Inherit Metab Dis 2018; 41: 839-848. https://doi. org/10.1007/s10545-018-0186-z
9. Liu S, Zhang W, Shi H, Meng Y, Qiu Z. Three novel homozygous mutations in the GNPTG gene that cause mucolipidosis type III gamma. Gene 2014; 535: 294-298. https://doi.org/10.1016/j.gene.2013.11.010
10. Gripp KW, Slavotinek AM, Hall JG, Allanson JE. Handbook of Physical Measurements (3rd ed). New York: Oxford University Press, 2007: 240-244.
11. Utine GE, Taşkıran EZ, Koşukcu C, et al. HERC1 mutations in idiopathic intellectual disability. Eur J Med Genet 2017; 60: 279-283. https://doi. org/10.1016/j.ejmg.2017.03.007
12. Spranger JW, Brill PW, Hall C, Nishimura G, Superti- Furga A, Unger S. Bone Dysplasias: An Atlas of Genetic Disorders of Skeletal Development (4th ed). New York: Oxford University Press, 2018: 129-130. https://doi.org/10.1093/med/9780190626655.001.0001